Cardiovascular Magnetic Resonance in the Evaluation of Heart Valve Disease

Overview

Journal BMC Med Imaging

Publisher Biomed Central

Specialty Radiology

Date 2017 Dec 30

PMID 29284450

Citations 20

Authors

G S Gulsin

A Singh

G P McCann

Affiliations

Soon will be listed here.

Abstract

Background: Over the last 25 years, cardiovascular magnetic resonance imaging (CMR) has emerged as an alternative to echocardiography for assessment of valvular heart disease (VHD). Although echo remains the first-line imaging modality for the assessment of patients with VHD, CMR can now provide a comprehensive assessment in many instances. Using a combination of techniques, CMR provides information on valve anatomy and enables quantitative analysis of the severity of the valve lesion.

Main Text: In this review, the fundamentals of CMR in assessment of VHD are described, together with its strengths and weaknesses. We detail the utility of CMR for studying all aspects of VHD, including valve anatomy, flow quantification as well as ventricular volumes and function. The optimisation of CMR for evaluating the commonest valve lesions (aortic stenosis, aortic regurgitation, mitral regurgitation, mitral stenosis) as well as in right-sided VHD and prosthetic valves is summarised. The focus of this review is to enable the reader to optimise the use of CMR in his or her own evaluation of heart valve lesions in clinical practice.

Conclusions: CMR can be used for the comprehensive evaluation of VHD. This exciting, non-invasive imaging modality is likely to have increasing utility in the clinical evaluation of patients with VHD.

Citing Articles

Atrial Functional Tricuspid Regurgitation: A Comprehensive Review of Pathophysiology, Diagnosis, and Management Strategies.

Mohyeldin M, Abdelghafar A, Allu S, Shrivastava S, Mustafa A, Mohamed F Rev Cardiovasc Med. 2025; 25(12):435.

PMID: 39742228 PMC: 11683701. DOI: 10.31083/j.rcm2512435.

Cardiovascular magnetic resonance in patients with mitral valve prolapse.

Figliozzi S, Di Maio S, Georgiopoulos G, Vandenberk B, Chiribiri A, Francone M J Cardiovasc Magn Reson. 2024; 27(1):101137.

PMID: 39725235 PMC: 11786644. DOI: 10.1016/j.jocmr.2024.101137.

Novel contouring method for optimizing MRI flow quantification in patients with aortic valve disease.

Yaman M, Chetrit M, Bullen J, Bolen M, Flamm S, Kwon D Int J Cardiovasc Imaging. 2024; 40(3):665-673.

PMID: 38286950 PMC: 10950979. DOI: 10.1007/s10554-023-03036-0.

Assessment of Microvascular Disease in Heart and Brain by MRI: Application in Heart Failure with Preserved Ejection Fraction and Cerebral Small Vessel Disease.

Bennett J, van Dinther M, Voorter P, Backes W, Barnes J, Barkhof F Medicina (Kaunas). 2023; 59(9).

PMID: 37763715 PMC: 10534635. DOI: 10.3390/medicina59091596.

Mitral and Tricuspid Valve Disease in Athletes.

Segreti A, Celeski M, Monticelli L, Perillo A, Crispino S, Di Gioia G J Clin Med. 2023; 12(10).

PMID: 37240669 PMC: 10219091. DOI: 10.3390/jcm12103562.

References

Andersson C, Kihlberg J, Ebbers T, Lindstrom L, Carlhall C, Engvall J . Phase-contrast MRI volume flow--a comparison of breath held and navigator based acquisitions. BMC Med Imaging. 2016; 16:26. PMC: 4809032. DOI: 10.1186/s12880-016-0128-x. View

Nishimura R, Otto C, Bonow R, Carabello B, Erwin 3rd J, Guyton R . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63(22):2438-88. DOI: 10.1016/j.jacc.2014.02.537. View

Carabello B . Clinical practice. Aortic stenosis. N Engl J Med. 2002; 346(9):677-82. DOI: 10.1056/NEJMcp010846. View

Shellock F . MR imaging of metallic implants and materials: a compilation of the literature. AJR Am J Roentgenol. 1988; 151(4):811-4. DOI: 10.2214/ajr.151.4.811. View

Myerson S, dArcy J, Mohiaddin R, Greenwood J, Karamitsos T, Francis J . Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation. 2012; 126(12):1452-60. DOI: 10.1161/CIRCULATIONAHA.111.083600. View

Klein A, Burstow D, Tajik A, Zachariah P, Taliercio C, Taylor C . Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr. 1990; 3(1):54-63. DOI: 10.1016/s0894-7317(14)80299-x. View

Bertelsen L, Svendsen J, Kober L, Haugan K, Hojberg S, Thomsen C . Flow measurement at the aortic root - impact of location of through-plane phase contrast velocity mapping. J Cardiovasc Magn Reson. 2016; 18(1):55. PMC: 5013573. DOI: 10.1186/s12968-016-0277-7. View

Ammash N, Dearani J, Burkhart H, Connolly H . Pulmonary regurgitation after tetralogy of Fallot repair: clinical features, sequelae, and timing of pulmonary valve replacement. Congenit Heart Dis. 2008; 2(6):386-403. DOI: 10.1111/j.1747-0803.2007.00131.x. View

Caduff J, Hernandez R, Ludomirsky A . MR visualization of aortic valve vegetations. J Comput Assist Tomogr. 1996; 20(4):613-5. DOI: 10.1097/00004728-199607000-00021. View

10.

Uretsky S, Gillam L, Lang R, Chaudhry F, Argulian E, Supariwala A . Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol. 2015; 65(11):1078-88. DOI: 10.1016/j.jacc.2014.12.047. View

11.

Nishimura R, Otto C, Bonow R, Carabello B, Erwin 3rd J, Guyton R . 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(23):e521-643. DOI: 10.1161/CIR.0000000000000031. View

12.

Heidenreich P, Steffens J, Fujita N, OSullivan M, Caputo G, Foster E . Evaluation of mitral stenosis with velocity-encoded cine-magnetic resonance imaging. Am J Cardiol. 1995; 75(5):365-9. DOI: 10.1016/s0002-9149(99)80555-4. View

13.

Nigri M, Azevedo C, Rochitte C, Schraibman V, Tarasoutchi F, Pommerantzeff P . Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology. Am Heart J. 2009; 157(2):361-8. DOI: 10.1016/j.ahj.2008.09.012. View

14.

Rebergen S, Chin J, Ottenkamp J, van der Wall E, de Roos A . Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation. 1993; 88(5 Pt 1):2257-66. DOI: 10.1161/01.cir.88.5.2257. View

15.

Buchner S, Debl K, Schmid F, Luchner A, Djavidani B . Cardiovascular magnetic resonance assessment of the aortic valve stenosis: an in vivo and ex vivo study. BMC Med Imaging. 2015; 15:34. PMC: 4548454. DOI: 10.1186/s12880-015-0076-x. View

16.

Miller C, Jordan P, Borg A, Argyle R, Clark D, Pearce K . Quantification of left ventricular indices from SSFP cine imaging: impact of real-world variability in analysis methodology and utility of geometric modeling. J Magn Reson Imaging. 2012; 37(5):1213-22. DOI: 10.1002/jmri.23892. View

17.

Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V . Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003; 107(7):984-91. DOI: 10.1161/01.cir.0000051865.66123.b7. View

18.

M Hasenkam J, Ringgaard S, Houlind K, Botnar R, Stodkilde-Jorgensen H, Boesiger P . Prosthetic heart valve evaluation by magnetic resonance imaging. Eur J Cardiothorac Surg. 1999; 16(3):300-5. DOI: 10.1016/s1010-7940(99)00215-8. View

19.

Cavalcante J, Schoenhagen P . Role of cross-sectional imaging for structural heart disease interventions. Cardiol Clin. 2013; 31(3):467-78. DOI: 10.1016/j.ccl.2013.04.006. View

20.

Carabello B . Modern management of mitral stenosis. Circulation. 2005; 112(3):432-7. DOI: 10.1161/CIRCULATIONAHA.104.532498. View